WHO: Strengthening Civil Society Engagement in the COVID-19 Response at the National and Local Levels – Vaccination, Decarceration and Community Reintegration of People in Prison amidst COVID-19 in Malaysia

On October 6, 2020, the Director General of Prison’s Department outlined specific measures to deal with the alarming rise of in-prison related COVID-19 cases. The Prison’s Department identified 11,018 prisoners with less than a year of sentence remaining to be eligible for a Release-on License program, according to the Prison...

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy (D²EFT)

First-line antiretroviral regimens are safe, effective and easily administered (one pill taken once daily). Even so, the annual failure rate is around 10-15% of treated patients. Second-line regimens have a number of limitations, disproportionately impacting resource-limited settings. Ideally choice of the second-line regimen is guided by expensive and technically demanding...

AmFAR, Foundation for AIDS Research: Treat Asia HIV Observational Database (TAHOD)

TREAT Asia has pioneered the first database to assess the natural history of HIV disease in treated and untreated patients throughout Asia and the Pacific. In an unprecedented regional collaboration on HIV research, 17 clinical sites in Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea,...

Strategic Timing of Anti-Retroviral Treatment (START Study)

The START trial was designed to address the question: In HIV-1 (subsequently referred to as HIV) infected asymptomatic participants with a CD4+ count greater than 500 cells/mm3, is immediate use of antiretroviral therapy (ART) superior to deferral of ART until the CD4+ count declines to 350 cells/mm3 or AIDS develops...

NIH: Implementing Stigma Reduction Tools Via A Popular Teletraining Platform To Reduce Clinician Stigma And Disparities In HIV Testing, Prevention, And Linkage To Care In Malaysia

A scalable intervention is needed to remove one of the most potent and persistent drivers of disparities in HIV testing, prevention, and linkage to care globally: clinician stigma toward key populations. Key populations at risk of HIV who experience and/or anticipate stigma from clinicians are less likely to initiate, engage...

Capacity development in HIV and MEntal health Research in Asia (CHIMERA)

Capacity development in HIV and MEntal health Research in Asia (CHIMERA) is being carried out with The Foundation for AIDS Research and is the region’s first HIV-mental health IR training program. CHIMERA is a five-year (2019 – 2024) HIV, mental health, and implementation science research training program funded by the Fogarty...